The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine

Clinical trial NCT05273528 · UNKNOWN

Trial details

NCT number: NCT05273528
Sponsor: Livzon Pharmaceutical Group Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Pandemic

Start date: 2022-01-11
Primary completion: 2023-01-06
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.